NCT05653804

Brief Summary

To determine the impact of telecare on continous positive airway pressure (CPAP) patients follow up by home care provider (HCP)

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Apr 2023May 2027

First Submitted

Initial submission to the registry

November 18, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 16, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 11, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2027

Expected
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

3.1 years

First QC Date

November 18, 2022

Last Update Submit

February 10, 2026

Conditions

Keywords

tele-visit

Outcome Measures

Primary Outcomes (1)

  • To compare CPAP compliance between the two management modalities

    CPAP mean compliance between intervention and control groups, adjusted for the three months prior to inclusion : in hours/day, collected on the CPAP remote monitoring report

    Over the 3 months (tele)visit follow-up

Secondary Outcomes (13)

  • To compare overall patient satisfaction between the two management modalities

    Immediately after the (tele-)visit follow-up

  • To compare the impact on daytime sleepiness between the two management modalities

    At 3 months after (tele-)visit follow-up

  • To compare impact on quality of life between the two management modalities

    At 3 months after (tele-)visit follow-up

  • To compare CPAP compliance in medium term between the two management modalities

    Over the 12 months (tele)visit follow-up

  • To compare impact on CPAP continuation between the two management modalities

    Over the 12 months (tele)visit follow-up

  • +8 more secondary outcomes

Other Outcomes (1)

  • To evaluate patient overall satisfaction regarding clinical study participation

    Over the 3 months (tele)visit follow-up

Study Arms (2)

tele-visit by HCP

EXPERIMENTAL

Patients receive a annual CPAP remote visit by HCP technician, then home visit the following year

Procedure: tele-visit

home visit by HCP

NO INTERVENTION

Standard care : patients receive an annual CPAP home visit by HCP technician

Interventions

tele-visitPROCEDURE

The remote visit content for CPAP follow up is based on home visit framework and carried out from a secure platform for sharing health data.

tele-visit by HCP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • CPAP ≥ 12 months and annual followed by "AGIR à dom" health care provider.

You may not qualify if:

  • Follow-up by AGIR à dom. for an other service than package F9.1 : CPAP follow-up and remote monitoring
  • Unacceptable level of mask leakage
  • Patient unavailable or willing to move within the next 12 months to an area not covered by AGIR à dom.
  • Patient considered by the investigator to be unfit for a tele-visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AGIR à dom.

Meylan, 38240, France

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Jean Christian BOREL, PhD

    AGIR à Dom

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Prospective, interventional, randomized controlled, open-label, single-center, multi-site
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2022

First Posted

December 16, 2022

Study Start

April 1, 2023

Primary Completion

May 11, 2026

Study Completion (Estimated)

May 11, 2027

Last Updated

February 12, 2026

Record last verified: 2026-02

Locations